Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.00%175.64B | 8.13%851.4B | 3.19%186.85B | -5.50%787.4B | -8.43%209.28B | -12.48%177.27B | -6.66%219.77B | 8.64%181.09B | 29.79%833.2B | 9.39%228.54B |
| Cost of revenue | -2.21%149.14B | 7.49%748.5B | -5.45%152.5B | -16.32%696.34B | -12.98%206.05B | -23.45%161.08B | -25.16%167.91B | 0.46%161.3B | 29.43%832.15B | 15.63%236.8B |
| Gross profit | -22.84%26.5B | 13.00%102.9B | 73.64%34.35B | 8,515.33%91.06B | 139.05%3.22B | 305.56%16.19B | 368.34%51.86B | 223.52%19.78B | 207.42%1.06B | -298.94%-8.25B |
| Operating expense | 7.67%3.86B | 10.27%13.83B | 14.89%3.59B | -6.04%12.54B | 1.36%3.27B | -11.97%3.07B | -8.35%3.07B | -4.67%3.12B | 6.46%13.34B | 5.18%3.23B |
| Operating profit | -26.40%22.64B | 13.43%89.07B | 84.65%30.76B | 739.16%78.53B | 99.56%-50M | 215.52%13.13B | 531.99%48.79B | 486.65%16.66B | 9.11%-12.29B | -1,164.23%-11.48B |
| Net non-operating interest income (expenses) | -7.25%-1.46B | -1.51%-5.51B | 2.15%-1.37B | 0.33%-5.43B | -4.22%-1.36B | 0.95%-1.35B | 9.81%-1.32B | -6.41%-1.4B | -10.24%-5.45B | -9.05%-1.3B |
| Non-operating interest income | 49.10%249M | 0.54%748M | -5.65%167M | 0.81%744M | -30.04%170M | 9.76%180M | 29.94%217M | 7.93%177M | 15.49%738M | 16.27%243M |
| Non-operating interest expense | 11.81%1.71B | 1.39%6.26B | -2.54%1.53B | -0.19%6.17B | -1.17%1.53B | 0.20%1.53B | -5.75%1.54B | 6.58%1.57B | 10.84%6.18B | 10.12%1.55B |
| Net investment income | -27.53%658M | 5.63%4.41B | 24.38%908M | -60.18%4.17B | 79.80%1.27B | -45.98%954M | -75.87%1.22B | -75.40%730M | 243.94%10.48B | -29.41%708M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 46.58%-1.06B | -509.05%-1.99B | -130.45%-2.53B | -50.21%467M | -88.25%76M | -50.00%-3M | 422.58%486M | -27,325.00%-1.1B | ||
| Income from associates and other participating interests | -47.82%671M | 18.27%5.47B | 498.14%1.29B | 163.14%4.63B | 131.11%2.73B | 17.29%658M | 223.97%1.03B | -61.47%215M | -461.83%-7.33B | -1,650.97%-8.76B |
| Special income (charges) | 0 | 0 | -8.01%-337M | -52.72%400M | 804.81%1.88B | 192.47%544M | -1,290.28%-1.71B | -201.30%-312M | -85.56%846M | -97.20%208M |
| Less:Other special charges | ---- | ---- | ---- | --2.61B | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --0 | --0 | 8.01%337M | 52.72%-400M | -804.81%-1.88B | -192.47%-544M | 1,290.28%1.71B | 201.30%312M | 87.11%-846M | 96.79%-208M |
| Other non-operating income (expenses) | -13.45%148M | -515.68%-769M | 124.12%171M | 102.20%185M | 99.01%-83M | 55.00%-54M | 418.09%1.03B | -399.30%-709M | -2,584.07%-8.42B | -5,585.71%-8.36B |
| Income before tax | -27.91%22.66B | 13.81%91.61B | 106.94%31.43B | 471.48%80.5B | 106.19%1.86B | 252.66%14.35B | 289.76%49.1B | 191.03%15.19B | -205.58%-21.67B | -444.57%-30.09B |
| Income tax | -0.54%7.3B | 16.73%23.11B | 120.44%7.34B | 1,786.94%19.79B | 55.39%-2.4B | 394.39%6.77B | 107.79%12.09B | 14.39%3.33B | 206.17%1.05B | -253.58%-5.38B |
| Net income | -36.25%15.35B | 12.86%68.51B | 103.16%24.08B | 367.18%60.7B | 117.25%4.26B | 206.68%7.57B | 445.85%37.01B | 414.27%11.85B | -272.32%-22.72B | -572.54%-24.71B |
| Net income continuous operations | -36.25%15.35B | 12.85%68.51B | 103.15%24.08B | 367.20%60.7B | 117.25%4.26B | 206.69%7.57B | 445.91%37.01B | 414.09%11.86B | -272.24%-22.72B | -572.52%-24.71B |
| Noncontrolling interests | 25.93%68M | -2.70%180M | 8.00%54M | 21.71%185M | -43.64%31M | 5,800.00%57M | 11.90%47M | -10.71%50M | -4.40%152M | 96.43%55M |
| Net income attributable to the company | -36.39%15.29B | 12.90%68.32B | 103.56%24.03B | 364.59%60.52B | 117.09%4.23B | 205.88%7.51B | 448.55%36.97B | 424.86%11.8B | -265.23%-22.87B | -576.21%-24.76B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -36.39%15.29B | 12.90%68.32B | 103.56%24.03B | 364.59%60.52B | 117.09%4.23B | 205.88%7.51B | 448.55%36.97B | 424.86%11.8B | -265.23%-22.87B | -576.21%-24.76B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -36.39%74.32 | 12.90%332.2 | 103.54%116.83 | 364.64%294.25 | 117.09%20.57 | 205.91%36.53 | 448.69%179.75 | 425.16%57.4 | -265.28%-111.19 | -576.23%-120.39 |
| Diluted earnings per share | -36.39%74.32 | 12.90%332.2 | 103.54%116.83 | 364.64%294.25 | 117.08%20.57 | 205.91%36.53 | 448.73%179.75 | 425.16%57.4 | -265.28%-111.19 | -576.39%-120.415 |
| Dividend per share | 0 | 33.33%40 | 0 | 30 | 15 | 0 | 15 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |